Management of stage II seminoma

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
P WardeMichael A S Jewett

Abstract

To assess the results of treatment, patterns of failure, and prognostic factors for relapse in a contemporary cohort of patients with stage II seminoma. From January 1981 and December 1993, 99 patients (median age, 35 years) with stage II seminoma (IIA, 41; IIB, 28; IIC, 24; IID, six) were managed at our institution. Eighty were treated with radiation therapy (RT) and 19 with chemotherapy (ChT). With a median follow-up of 6.7 years, the five-year overall actuarial survival was 94%, the 5-year cause-specific survival was 94%, and the 5-year relapse-free rate was 83%. Sixteen (20%) of the 80 patients treated with RT relapsed (median time to relapse, 9 months). Relapse occurred outside the irradiated area in all but two patients. Distant relapse sites included the supraclavicular fossa, bone (four patients, three with spinal cord compression), and lung/mediastinum. All 19 patients treated primarily with ChT achieved disease control and none has relapsed. The relapse rate at 5 years for patients with stage IIA to IIB was 11% (seven of 64), and 56% (nine of 16) for those with stage IIC to IID disease (P < .0001). No patient with IIC or IID disease treated with ChT relapsed as compared with 56% of patients treated with RT (0 of 14 v ...Continue Reading

Citations

Dec 10, 1999·Seminars in Surgical Oncology·M F MilosevicP Warde
Dec 10, 1999·Seminars in Surgical Oncology·G J Bosl
Aug 13, 2002·Current Opinion in Urology·Alan Horwich, Robert A Huddart
Jan 30, 2009·Anti-cancer Drugs·James F WatkinsStephen K Williamson
May 16, 2018·Oncology Research and Treatment·Gunhild von AmsbergAlexandros Papachristofilou
Jun 12, 2002·Current Treatment Options in Oncology·R S Foster
Sep 30, 2003·Medical and Pediatric Oncology·Margherita Lo CurtoPaolo Tamaro
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan OldenburgSophie D Fosså
Aug 12, 1999·BJU International·G M Mead
May 18, 1999·Current Opinion in Oncology·R T Oliver
Jan 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan Horwich
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria De SantisJörg Pont
Aug 9, 2011·Radiation Oncology·Noureddine BoujelbeneAbderrahim Zouhair
Oct 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xavier Garcia-del-MuroJosep R Germá-Lluch
Apr 18, 2009·World Journal of Urology·Jan OldenburgSophie D Fosså
Sep 18, 2007·Der Urologe. Ausg. A·S Langenkamp, P Albers
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johannes ClassenMichael Bamberg
May 20, 2004·European Urology·Peter W M ChungPadraig R Warde
Sep 22, 1998·Current Problems in Cancer·C R Nichols
Oct 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KregeUNKNOWN German Testicular Cancer Study Group (GTCSG)
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P GiannatempoA Necchi
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H J SchmollUNKNOWN European Germ Cell Cancer Consensus Group
Jan 22, 2005·Critical Reviews in Oncology/hematology·Stefania GoriMaurizio Marangolo
Oct 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C KollmannsbergerC Nichols
Dec 19, 2003·The Urologic Clinics of North America·Manish I PatelJoel Sheinfeld
Nov 16, 2021·World Journal of Urology·Julia HeinzelbeckerChristoph Oing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
P WardeMichael A S Jewett
Progress in Clinical and Biological Research
R E Stutzman
International Journal of Urology : Official Journal of the Japanese Urological Association
Tomomi KambaOsamu Ogawa
Seminars in Oncology
A Horwich, D P Dearnaley
© 2021 Meta ULC. All rights reserved